J. Casabar

Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma

Jennifer B Dennison, S. Hanash, I. Wistuba, 2022, Cancers.

SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1-Negative Lung Adenocarcinomas.

Jennifer B Dennison, S. Hanash, I. Wistuba, 2021, Journal of the National Cancer Institute.

Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential*

C. Metz, B. Sherry, Y. Al-Abed, 2016, The Journal of Biological Chemistry.

NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype

Jason T. George, J. Onuchic, S. Hanash, 2018, bioRxiv.

CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes.

Jennifer B Dennison, S. Hanash, O. Fiehn, 2020, JCO precision oncology.